MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with R

Ruxolitinib

Ruxolitinib 5mg tablets

No stability information

Stability notes for Ruxolitinib 5mg tablets

There are no stability notes for this medicine.

Supplier

Jakavi 5mg tablets (Novartis Pharmaceuticals UK Ltd)

Ruxolitinib 10mg tablets

No stability information

Stability notes for Ruxolitinib 10mg tablets

There are no stability notes for this medicine.

Supplier

Jakavi 10mg tablets (Novartis Pharmaceuticals UK Ltd)

Ruxolitinib 15mg tablets

No stability information

Stability notes for Ruxolitinib 15mg tablets

There are no stability notes for this medicine.

Supplier

Jakavi 15mg tablets (Novartis Pharmaceuticals UK Ltd)

Ruxolitinib 20mg tablets

No stability information

Stability notes for Ruxolitinib 20mg tablets

There are no stability notes for this medicine.

Supplier

Jakavi 20mg tablets (Novartis Pharmaceuticals UK Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.